证券代码：301293 证券简称：三博脑科 公告编号：2025-049 三博脑科医院管理集团股份有限公司 关于与专业投资机构共同投资认购的基金存续期变更并签订补充协 议的公告 算，其中投资期为 4 年，退出期为 3 年。 一、与专业投资机构共同投资概述 为不断完善三博脑科医院管理集团股份有限公司（以下简称"公司"）产业链， 不断提升公司的临床诊疗水平，进一步增强公司的科技赋能，同时为充分利用资 本市场平台优势，借助专业投资机构的管理水平和投资经验，公司以有限合伙人 身份认购北脑一期（北京）股权投资中心（有限合伙）（以下简称"基金"、"合 伙企业"）部分份额，合伙企业募集资金总额为 9,000 万元，公司以自有资金 1,000 万元认购 11.11%的基金份额。具体内容详见公司于 2025 年 8 月 27 日在巨潮资 讯网（www.cninfo.com.cn）披露的《关于与专业投资机构共同投资认购基金份额 的公告》。 二、存续期变更情况说明 鉴于基金的原定存续期为 7 年，到期日为 2032 年 11 月 19 日，与基金的有 限合伙人之一北京北脑创业投资基金（有限合伙）的到期日（2031 年 2 月 17 ...

交易所数据显示，12月12日，三博脑科收盘54.12元，上涨1.61%，滚动市盈率PE（当前股价与前四季度 每股收益总和的比值）达到132.55倍，总市值111.48亿元。 来源：市场资讯 从行业市盈率排名来看，公司所处的医疗服务行业市盈率平均49.50倍，行业中值61.79倍，三博脑科排 名第38位。 最新一期业绩显示，2025年三季报，公司实现营业收入12.73亿元，同比增加20.26%；净利润8362.82万 元，同比减少20.01%，销售毛利率24.87%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13三博脑科132.55106.144.77111.48亿行业平均 49.5056.564.48189.39亿行业中值61.7964.023.0773.90亿1药明康德18.7229.693.962806.22亿2普蕊斯 30.7035.062.9837.31亿3诺禾致源31.8528.362.1555.81亿4爱尔眼科32.1929.134.621036.05亿5华康洁净 32.6452.931.9435.36亿6凯莱英32.6635.751.96339.25亿7通策医疗35.0136.11 ...

证券日报网讯12月11日晚间，三博脑科（301293）发布公告称，持股5%以上股东 TBP3Doctors(HK)Limited于2025年9月11日至12月10日通过集中竞价减持100万股，占剔除回购账户后总 股本0.493%，减持计划届满。 ...

证券代码：301293 证券简称：三博脑科 公告编号：2025-047 三博脑科医院管理集团股份有限公司 关于对子公司担保进展公告 一、担保情况概述 三博脑科医院管理集团股份有限公司（以下简称"公司"）分别于 2025 年 10 月 27 日、2025 年 11 月 12 日召开了第三届董事会第十五次会议和 2025 年第二 次临时股东会，审议通过了《关于为子公司提供担保额度预计的议案》，同意公 司为下属公司的融资提供担保额度总计不超过人民币 92,442.83 万元，其中有两 笔是为控股子公司西安三博脑科医院有限公司（以下简称"西安三博"）提供的担 保，两笔担保额度分别为 5,000 万元和 4,135.95 万元。担保方式包括但不限于保 证、抵押；担保期限以实际签署的担保协议为准。公司可以根据实际情况，在上 述额度范围内，在符合要求的担保对象之间进行担保额度的调剂，对资产负债率 超过 70%的担保对象提供担保，仅能从资产负债率超过 70%（审议担保额度时） 的担保对象处获得担保额度。 具体内容详见公司于 2025 年 10 月 28 日在巨潮资讯网披露的《关于为子公 司提供担保额度预计的公告》。 二、担保 ...

早盘，工业母机概念震荡反弹，中国一重直线涨停。国机重装此前封板，维宏股份、宇环数控、睿能科技、力星股份等跟涨。 | | | | 工业母机 ① | | | --- | --- | --- | --- | --- | | | | | 1754.21 1.29% | | | 成分股 | 星金 | 资金 | 分析 | 新闻 简況(F10) | | 名称/代码 | | | 最新 ◆ | 涨幅 ◆ 5日涨幅 ◆ ▶ | | 国机重装 601399 園 | | | 4.63 | +9.98% +42.46% | | 人气龙头２ 领涨龙头２ 3天3板 | | | 最终涨停 10:12 | | | 中国一重 | | | 3.42 | +9.97% +13.62% | | 601106 融 首板 最终涨停10:26 | | | | | | 维宏股份 | | | 38.12 | +9.29% +10.05% | | 创 300508 | | | | | | 宇环数控 | | | 24.54 | +6.70% +0.61% | | 002903 融 | | | | | | 最终涨停 10:18 | | | | | | 睿能科技 | ...

格隆汇12月2日丨三博脑科(301293.SZ)在投资者互动平台表示，截至目前三博脑科已完成1例，为此前 下属福建院区完成的介入式脑机接口试验手术。 ...

Core Points - The Shenzhen-Hong Kong Medical Index (983035) closed at 4554.17 points, up 0.2%, with a trading volume of 7.409 billion yuan and a turnover rate of 0.81% [1] - Among the index constituents, 38 stocks rose while 17 fell, with Yidu Technology leading the gainers at 3.5% and Mylab leading the decliners at 4.98% [1] Index Constituents Summary - The top ten constituents of the Shenzhen-Hong Kong Medical Index include: - Mindray Medical (sz300760) with a weight of 14.56% and a latest price of 201.62, down 1.17% [1] - Aier Eye Hospital (sz300015) with a weight of 11.62% and a latest price of 11.57, up 0.61% [1] - Lepu Medical (sz300003) with a weight of 4.85% and a latest price of 16.00, up 0.38% [1] - Aimeike (sz300896) with a weight of 4.80% and a latest price of 146.00, up 0.43% [1] - Yuyue Medical (sz002223) with a weight of 4.66% and a latest price of 36.25, up 1.54% [1] - Yingke Medical (sz300677) with a weight of 3.64% and a latest price of 43.48, up 0.95% [1] - Furuide (sz300049) with a weight of 3.59% and a latest price of 69.38, up 2.53% [1] - Meinian Health (sz002044) with a weight of 3.58% and a latest price of 5.27, down 1.50% [1] - Sinopharm (hk01099) with a weight of 3.35% and a latest price of 18.58, up 2.00% [1] - Ping An Good Doctor (hk01833) with a weight of 2.63% and a latest price of 13.53, up 1.22% [1] Capital Flow Analysis - The net outflow of main funds from the index constituents totaled 172 million yuan, while retail funds saw a net inflow of approximately 84.92 million yuan [3] - Notable capital flows include: - Sanbo Brain Science (301293) with a main fund net inflow of 26.77 million yuan [3] - Ruimait (301367) with a main fund net inflow of 16.21 million yuan [3] - Chutian Technology (300358) with a main fund net inflow of 11.20 million yuan [3] - The index constituents underwent an adjustment with one new stock added in the last ten days [3]

Core Points - The Shenzhen-Hong Kong Medical Index (983035) closed at 4494.42 points, up 0.15%, with a trading volume of 7.52 billion yuan and a turnover rate of 0.75% [1] - Among the index constituents, 32 stocks rose while 24 fell, with Medical Pulse leading the gainers at 3.65% and Health Road leading the decliners at 3.41% [1] Index Constituents Summary - The top ten constituents of the Shenzhen-Hong Kong Medical Index include: - Mindray Medical (14.56% weight, latest price 196.30 yuan, market cap 238 billion yuan, up 1.50%) [1] - Yier Eye Hospital (11.62% weight, latest price 11.40 yuan, market cap 106.31 billion yuan, down 0.26%) [1] - Lejin Medical (4.85% weight, latest price 15.87 yuan, market cap 29.26 billion yuan, up 0.13%) [1] - Aimeike (4.80% weight, latest price 146.26 yuan, market cap 44.26 billion yuan, up 0.83%) [1] - Yuyue Medical (4.66% weight, latest price 35.70 yuan, market cap 35.79 billion yuan, down 0.67%) [1] - Yingke Medical (3.64% weight, latest price 41.53 yuan, market cap 27.21 billion yuan, up 1.94%) [1] - Furuide (3.59% weight, latest price 67.08 yuan, market cap 17.78 billion yuan, up 1.36%) [1] - Meinian Health (3.58% weight, latest price 5.28 yuan, market cap 20.67 billion yuan, down 1.68%) [1] - Sinopharm (3.35% weight, latest price 18.42 yuan, market cap 57.48 billion yuan, down 0.69%) [1] - Ping An Good Doctor (2.63% weight, latest price 13.66 yuan, market cap 29.52 billion yuan, down 1.83%) [1] Capital Flow Analysis - The net outflow of main funds from the index constituents totaled 58.83 million yuan, while retail investors saw a net inflow of 78.07 million yuan [1] - Specific stock capital flows include: - Aimeike: Main fund net inflow of 46.99 million yuan, retail net outflow of 30.07 million yuan [2] - Mindray Medical: Main fund net inflow of 33.08 million yuan, retail net outflow of 17.11 million yuan [2] - Furuide: Main fund net inflow of 13.68 million yuan, retail net outflow of 19.08 million yuan [2] Recent Adjustments - The Shenzhen-Hong Kong Medical Index has undergone adjustments in the last 10 days, with one new stock added [2]

Market Overview - The medical services sector declined by 0.47% on November 14, with the digital human sector leading the drop [1] - The Shanghai Composite Index closed at 3990.49, down 0.97%, while the Shenzhen Component Index closed at 13216.03, down 1.93% [1] Stock Performance - Notable declines in individual stocks include: - Digital Human: closed at 17.28, down 4.85% with a trading volume of 80,400 shares and a turnover of 1.411 million [1] - Haoyuan Pharmaceutical: closed at 77.20, down 3.54% with a trading volume of 30,800 shares and a turnover of 2.4212 million [1] - Yinos: closed at 48.69, down 2.62% with a trading volume of 14,300 shares and a turnover of 7132.217 [1] - Other notable declines include Taige Pharmaceutical, MediX, and WuXi AppTec, all showing declines between 1.28% and 2.08% [1] Capital Flow - The medical services sector experienced a net outflow of 238 million yuan from institutional investors, while retail investors saw a net inflow of 181 million yuan [3] - Notable capital flows for specific stocks include: - Ruizhi Pharmaceutical: net inflow of 38.93 million yuan from institutional investors, but net outflows from retail and speculative investors [3] - Chengda Pharmaceutical: net inflow of 37.96 million yuan from institutional investors, with significant outflows from speculative investors [3] - Other stocks like Sanbo Brain Science and Jinyu Medical also showed varying net inflows and outflows among different investor types [3]

Core Insights - The brain engineering sector is leading the market with a rise of 1.05% [1] Company Performance - Aipeng Medical saw a significant increase of 7.51% [1] - Innovation Medical experienced a rise of 4.41% [1] - Century Huatong increased by 3.41% [1] - Chengyitong, Xiangyu Medical, and Sanbo Brain Science all rose by over 2% [1]